GlucoTrack Inc. (NASDAQ: GCTK)
$1.61
-0.0500 ( -3.01% ) 11.9K
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Market Data
Open
$1.61
Previous close
$1.66
Volume
11.9K
Market cap
$8.71M
Day range
$1.58 - $1.73
52 week range
$0.66 - $4.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | May 15, 2024 |
8-k | 8K-related | 13 | May 02, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
3 | Insider transactions | 1 | Apr 24, 2024 |
def | Proxies and info statements | 1 | Apr 01, 2024 |
10-k | Annual reports | 63 | Mar 28, 2024 |
pre | Proxies and info statements | 1 | Mar 22, 2024 |
8-k | 8K-related | 15 | Feb 16, 2024 |
8-k | 8K-related | 37 | Jan 11, 2024 |
8-k | 8K-related | 14 | Jan 02, 2024 |